Publications by authors named "Monica Ceccon"

16Publications

In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib.

J Hematol Oncol 2015 Jul 7;8:81. Epub 2015 Jul 7.

Department of Health sciences, University of Milano-Bicocca, S.Gerardo Hospital, Monza, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-015-0179-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491863PMC
July 2015

Ceritinib as a promising therapy for ALK related diseases.

Authors:
Monica Ceccon

Transl Lung Cancer Res 2014 Dec;3(6):376-8

Department of Health Science, University of Milano Bicocca, Monza, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2014.08.09DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367665PMC
December 2014

Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients.

J Natl Cancer Inst 2014 Feb;106(2):djt378

Affiliations of authors: Department of Health Sciences, University Milano Bicocca, Monza, Italy (CGP, FF, AS, SR, MC, LMo, CM, LA, RP); Hematology Unit (CGP) and Nuclear Medicine and PET Unit (CM, LG), San Gerardo Hospital, Monza, Italy; M Tettamanti Research Center, Pediatric Clinic University of Milano Bicocca, Monza, Italy (GG); Medical Genetics Laboratory, San Gerardo Hospital, Monza, Italy (ES); Istituto di Ricerca Pediatrico Fondazione Città della Speranza, Pediatric Clinic University of Padova, Padova, Italy (LMu); H.-Hartziekenhuis Roeselare-Menen vzw, Roeselare, Belgium (DD); Trillium Health Centre, Mississauga Site, Mississauga ON, Canada (MHK); Division of Hematology and Oncology, Innsbruck Medical University, Innsbruck, Austria (MS); Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany (RO); Hematology Institute, Beilinson Hospital, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (AMC); Department of Haematology and Internal Oncology, University Hospital Regensburg, Regensburg, Germany (MG); Hematology/Stem Cell Transplantation, Maisonneuve Rosemont/University of Montreal, Montreal, QC, Canada (LB); School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland (GC).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt378DOI Listing
February 2014

Crizotinib-resistant NPM-ALK mutants confer differential sensitivity to unrelated Alk inhibitors.

Mol Cancer Res 2013 Feb 13;11(2):122-32. Epub 2012 Dec 13.

Department of Health Sciences, University of Milano-Bicocca, Via Cadore 48, Monza 20900, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-12-0569DOI Listing
February 2013

Three novel patient-derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors.

Am J Hematol 2012 Nov 9;87(11):E125-8. Epub 2012 Oct 9.

Department of Clinical Medicine and Prevention, University of Milano-Bicocca, S. Gerardo Hospital, Monza, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23338DOI Listing
November 2012

Colorectal tumors are effectively eradicated by combined inhibition of {beta}-catenin, KRAS, and the oncogenic transcription factor ITF2.

Cancer Res 2010 Sep 7;70(18):7253-63. Epub 2010 Sep 7.

University of Milano Bicocca, Monza, Italy; McGill University, Montreal, Canada; and National Cancer Institute, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-1108DOI Listing
September 2010

iNKT cells control mouse spontaneous carcinoma independently of tumor-specific cytotoxic T cells.

PLoS One 2010 Jan 13;5(1):e8646. Epub 2010 Jan 13.

Cellular Immunology Unit, Division of Immunology, Transplantation and Infectious Diseases, Istituto Scientifico San Raffaele, Milan, Italy.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008646PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800182PMC
January 2010